Latest Drug Delivery News

Page 6 of 6

InhaleRx Secures $38.5M to Accelerate Inhaled Drug Trials for Cancer Pain and Panic Disorder

InhaleRx has corrected its quarterly report and revealed a $38.5 million funding deal to fast-track clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, aiming for FDA approval.

Ada Torres

24 Jan 2025

Top